Clinical Trial Details

POLARIS: USOR 16128

POLARIS: PALBOCICLIB IN HORMONE RECEPTOR POSITIVE ADVANCED BREAST CANCER: A PROSPECTIVE MULTICENTER NON-INTERVENTIONAL STUDY

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Breast Cancer
Study Type: Non-Interventional
Phase: N/A
Study Start Date: 05/31/17
Study Completion Date: 01/2021

Palbociclib in Hormone Receptor Positive Advanced Breast Cancer, Non-Interventional

NCT Number

NCT03280303

Principal Investigator(s)

John Wallmark, MD

Sponsor(s)

Pfizer

Participant Eligibility

• Age: 18 - No Maximum
• Gender: Male, Female